Every slot on IonQ’s (NYSE: IONQ) Superion 256 quantum system for 2027 has been booked solid, with customer orders now spilling into 2028.
That demand signal arrived alongside a third-quarter revenue figure of $173.8 million, a 336% year-over-year increase that cleared analyst consensus by roughly $32 million.
The market responded immediately, sending IonQ shares up 23.4% on Friday to $33, a move that dragged other listed quantum computing stocks higher by 18% to 19% on the same session.
Wall Street’s average price target implies the stock still has 85% further to travel, even after the single-day surge, according to estimates tracked across 14 analysts covering the company.
The revenue number has two distinct contributors: platform revenue of $90.3 million, up 127% driven by global Tempo system deployments, and SkyWater foundry revenue of $83.5 million following IonQ’s acquisition of the chipmaker earlier this year.
Stripping out the SkyWater consolidation, the 127% platform growth rate is the cleaner indicator of underlying quantum computing demand, and it remains notably strong by any industry measure.
IonQ’s own segment backlog climbed from $485 million to $689 million during the quarter, reflecting approximately $290 million in newly signed contracts, with remaining performance obligations across the business reaching $1.2 billion.
Management has raised full-year revenue guidance to a range of $505 million to $515 million, the third upward revision this year, compared to a prior range of $450 million to $460 million, and expects quantum computing revenue to more than double in 2026.
Beneath the headline numbers, the profit and loss picture requires careful reading: the reported $564 million net income, or $1.42 per share, was driven almost entirely by an $896 million non-cash warrant revaluation gain, supplemented by a $141.7 million tax benefit connected to the SkyWater deal.
The operating reality runs in the opposite direction, with the adjusted EBITDA loss widening to $133.6 million from $48.9 million a year earlier, while integration expenses added a further $40 million to costs.
IonQ has been funding its expansion aggressively through equity, paying for its Elisity acquisition with up to $1.3 billion in stock, closing a $2 billion stock and warrant offering in October, and issuing additional shares for SkyWater.
That dilution has purchased a pro forma cash position of $3.7 billion, giving the company significant runway even as operating losses accelerate.
The stock trades at roughly 16.5 times forward sales, a multiple that reflects how much future growth the market is already pricing in at current levels.
Despite Friday’s rally, IonQ shares remain 56% below their 52-week high, and the nearest test of the recovery’s durability arrives November 14, when lock-up agreements on certain shares, warrants, and options are scheduled to expire.
The February 24 earnings report will then serve as the next major checkpoint, with investors watching whether the $505 million to $515 million annual guidance holds and whether management can demonstrate a narrowing EBITDA loss as it has indicated.
